title: [Non-viral gene therapy approach for regenerative recovery of skin wounds in mammals].
abstract: The rate and character of skin tissue regeneration after wounds, burns and other traumas depend on the cell proliferation within damaged area. Acceleration of healing by stimulation of cell proliferation and extracellular matrix synthesis is one of the most important tasks of modern medicine. There are gene therapy approaches to wound treatment consisting in the transfer of genes encoding mitogenic growth factors to wound area. The most important step in the development of gene therapy approaches is the design of gene delivery tools. In spite of high efficacy of viral vectors, the non-viral means have some preferences (low toxicity, low immunogenity, safety and the absence of backside effects). Among non-viral gene delivery tools, molecular conjugates are the most popular because of their efficacy, simplicity, and the capacity to the targeted gene transfer. In the present work we have developed two molecular conjugates--NLS-TSF7 and NLS-TSF12 consisting of the modified signal of nuclear localization of T-antigen of SV40 virus (cationic part) and the peptide ligands of mammalian transferrin receptor (ligand part). These conjugates bind to plasmid DNA with formation of polyelectrolytic complexes and are capable to deliver plasmid DNA into cells expressing transferrin receptors by receptor-mediated endocytosis. Transfer of the expression vector of luciferase gene in the complex with molecular conjugate NLS-TSF7 to murine surface tissues led to about 100 fold increasing of luciferase activity in comparison with the transfer of free expression vector. Treatment of slash wounds in mice with the complexes of expression vector of synthetic human gene encoding insulin-like growth factor 1 with molecular conjugates NLS-TSF7 led to acceleration of healing in comparison with mice treated with free expression vector. The results obtained confirm the high efficiency of the developed regenerative gene therapy approach for the treatment of damaged skin tissues in mammals.
authors.forename: A M
authors.initials: AM
authors.lastname: Efremov
authors.forename: I V
authors.initials: IV
authors.lastname: Dukhovlinov
authors.forename: E B
authors.initials: EB
authors.lastname: Dizhe
authors.forename: S V
authors.initials: SV
authors.lastname: Burov
authors.forename: M V
authors.initials: MV
authors.lastname: Leko
authors.forename: B N
authors.initials: BN
authors.lastname: Akif'ev
authors.forename: D A
authors.initials: DA
authors.lastname: Mogilenko
authors.forename: I A
authors.initials: IA
authors.lastname: Ivanov
authors.forename: A P
authors.initials: AP
authors.lastname: Perevozchikov
authors.forename: S V
authors.initials: SV
authors.lastname: Orlov
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D005813:Genes, Synthetic / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D015552:Injections, Intralesional; D007334:Insulin-Like Growth Factor I / Q000235:genetics / Q000378:metabolism; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D019913:Nuclear Localization Signals / Q000378:metabolism; D010957:Plasmids / Q000235:genetics; D011990:Receptors, Transferrin / Q000378:metabolism; D012871:Skin Diseases / Q000628:therapy*; D014162:Transfection / Q000379:methods*; D014945:Wound Healing
chemical_list: D019913:Nuclear Localization Signals; D011990:Receptors, Transferrin; D007334:Insulin-Like Growth Factor I